Allkem Limited (OROCF)
| Previous Close | 8.34 |
| Open | 8.57 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 8.57 - 8.95 |
| 52 Week Range | 4.23 - 10.36 |
| Volume | |
| Avg. Volume | 44,619 |
| Market Cap | 5.853B |
| Beta (5Y Monthly) | 1.76 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Is Allkem (ASX:AKE) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
- GlobeNewswire
March 2022 Quarterly Activities Report
Figure 3 Inflation versus devaluation from April 2011- March 2022 BRISBANE, Australia, April 14, 2022 (GLOBE NEWSWIRE) -- Allkem Limited (ASX|TSX: “AKE”, the “Company”) provides an update on its global lithium portfolio, business activities and financial position1 at 31 March 2022. HIGHLIGHTS ALLKEM STRATEGY Plans to increase lithium production 3-fold by 2026 and maintain a 10% share of the global lithium market over the next decade were outlined at an investor briefing in early April2.5x increa
- GlobeNewswire
Sal de Vida capacity increased to 45ktpa in two stages
Not for release or distribution in the United States BRISBANE, Australia , April 04, 2022 (GLOBE NEWSWIRE) -- Allkem Limited (ASX|TSX: AKE, Allkem or the Company) advises an update to its wholly owned Sal de Vida Project located in Catamarca Province in Argentina. HIGHLIGHTS Project Summary Key changes from the 2021 Feasibility Study includes an increase in total planned capacity to 45,000 tpa, an increase in the capacity of Stage 1 and consolidation of Stages 2 and 3 into a single expansionRevi
